Premium
Five major global private equity firms - Warburg Pincus, Permira, EQT, Bain, and TPG - are interested in acquiring Bharat Serums and Vaccines (BSV) as the company's current owners seek a valuation exceeding $1 billion, a media report said. These firms are expected to formalize their interest within the next two weeks and initiate due diligence procedures, The Economic Times reported, ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
